— Know what they know.
Not Investment Advice

PPD

PPD, Inc.
1W: +0.4% 1M: +0.0% 3M: +1.3% 1Y: +33.8%
$47.28
Last traded 2021-12-07 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range47.24-47.4
Volume1,868,187
Avg Volume1,438,713
Beta0.00
Dividend
Analyst Ratings
6 Buy 9 Hold 0 Sell
Consensus Hold
Company Info
CEODavid S. Simmons
Employees30,000
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2020-02-06
Websiteppd.com
929 North Front Street
Wilmington, NC 28401-3331
US
19102510081
About PPD, Inc.

PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Carlyle Group Inc. J-Other 55,722,733 $47.50 2021-12-08
H&F Corporate Invest S-Sale 157,138 $47.50 2021-12-08
Johnston David Micha A-Award 33,228 $10.59 2021-12-08
Johnston David Micha A-Award 25,522 2021-12-08
Johnston David Micha D-Return 151,747 $37.22 2021-12-08

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms